Related Experiment Video
Updated: Aug 10, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Insights
Uremic acquired cystic kidney disease (ACDK) is common in male hemodialysis patients, increasing kidney cancer risk. Regular screening and renal transplantation are recommended for managing ACDK and its complications.
Area of Science:
- Nephrology
- Oncology
- Urology
Background:
- Uremic acquired cystic kidney disease (ACDK) is a condition affecting kidneys in patients with end-stage renal insufficiency.
- ACDK is particularly prevalent in male patients undergoing long-term hemodialysis.
- ACDK is associated with complications such as tumors, bleeding, and abscesses, with kidney cancer being a significant concern.
Purpose of the Study:
- To highlight the high incidence of ACDK in hemodialysis patients.
- To emphasize the association between ACDK and kidney cancer.
- To recommend screening and management strategies for ACDK.
Main Methods:
- Review of incidence rates of ACDK, tumors, and kidney cancer in hemodialysis patients.
- Clinical presentation analysis for ACDK and its complications.
- Evaluation of diagnostic tools like ultrasonic examination and CT scans.
- Assessment of treatment outcomes, including renal transplantation.
Main Results:
- ACDK occurs in 47.1% of hemodialysis patients.
- Tumors and kidney cancer are observed in 4.8% and 1.5% of hemodialysis patients, respectively.
- Symptoms like gross hematuria, flank pain, decreased hematocrit, and fever may indicate ACDK or complications.
Conclusions:
- ACDK poses a significant risk for kidney cancer, even without overt symptoms.
- Regular screening via ultrasound or CT scans is crucial for early detection.
- Renal transplantation can lead to regression of ACDK.
- ACDK warrants classification as a distinct renal cystic disease and serves as a model for studying cyst and tumor development.
Abstract:
Multiple cystic disease occurring in the diseased kidneys of patients with end-stage renal insufficiency is called uremic acquired cystic disease of the kidney. In male patients undergoing long-term hemodialysis the incidence of ACDK is markedly high. ACDK is known to be accompanied by tumor, bleeding, calculus, abscess, etc., and the complication of cancer of the kidney is a special problem. In patients undergoing hemodialysis, occurrence of ACDK, tumor, and kidney cancer are observed respectively at the rate of 47.1, 4.8, and 1.5 per cent. When hemodialysis patients show gross hematuria, flank pain, rapid decrease in hematocrit, and sustained fever, ACDK or its complications should be investigated. Since the risk accompanied by kidney cancer is high in spite of a lack of symptoms, regular screening by ultrasonic examination or CT scan is needed. Renal transplantation is also recommended because of the regression of ACDK after successful renal transplantation. In the future, it appears that ACDK should be considered one disease entity and added to the categories of renal cystic diseases. In addition, ACDK can be studied as a model for clarification of the mechanism of cyst and tumor occurrence.
Related Concept Videos
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management

